44 WEALTH MANAGEMENT LLC

Position in LLY — ELI LILLY & Co

CIK 1831187 EUGENE, OR

Position in LLY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,029,111

+$212,356 QoQ

Shares Held

858

-3.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.34%

of 13F equity value

Holder Rank

#3,123

of 4,605 holders

Holding Since

Dec 2020

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

44 WEALTH MANAGEMENT LLC holds $16,913,142 across 10 Drug Manufacturers - General names. LLY ranks #5 (6.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	23,812	$6,047,533
2	BMY	Bristol Myers Squibb Co	65,070	$3,749,333
3	MRK	Merck & Co., Inc.	15,847	$2,036,339
4	SNY	Sanofi	43,343	$1,849,012
5	LLY	ELI LILLY & Co This page	858	$1,029,111
6	AZN	Astrazeneca PLC	2,817	$534,159
7	NVS	Novartis AG	3,161	$495,391
8	AMGN	Amgen Inc	1,359	$492,121

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,029,111	858	-3.4%	Shares	Sole	2026-08-14
2026-03-31	$816,755	888	0.0%	Shares	Sole	2026-05-15
2025-12-31	$954,315	888	-24.9%	Shares	Sole	2026-02-09
2025-09-30	$902,629	1,183	-3.0%	Shares	Sole	2025-11-14
2025-06-30	$950,247	1,219	-24.4%	Shares	Sole	2025-08-15
2025-03-31	$1,332,192	1,613	-9.6%	Shares	Sole	2025-04-29
2024-12-31	$1,377,248	1,784	-12.0%	Shares	Sole	2025-02-03
2024-09-30	$1,796,686	2,028	+0.3%	Shares	Sole	2024-10-25
2023-06-30	$947,808	2,021	+31.4%	Shares	Sole	2023-07-18
2023-03-31	$528,179	1,538	0.0%	Shares	Sole	2023-04-20
2022-12-31	$562,661	1,538	+109.8%	Shares	Sole	2023-01-20
2022-09-30	$237,015	733	+5.3%	Shares	Sole	2022-10-12
2022-06-30	$225,664	696	-91.9%	Shares	Sole	2022-07-22
2021-06-30	$1,965,150	8,562	+381.6%	Shares	Sole	2021-07-19
2020-12-31	$300,197	1,778	—	Shares	Sole	2021-03-05
No filing history on record for this holder in this stock.